DePuy Orthopaedics, a Johnson and Johnson company, announced on August 24th that they were issuing an urgent voluntary hip replacement recall after discovering a high rate of modification necessary for their hip resurfacing product. Two of their products in particular are targeted by this recall: the ASR XL Acetabular Sytem and the DePuy ASR Hip Resurfacing System.
DePuy actually received notice from the National Joint Registry in the UK in March that 8 percent of their product’s recipients were required to undergo correctional surgery within the first three years, particularly when small, 50mm or less, pieces of the ASR System were used.
New data revealed that within merely 5 years, the number of recipients requiring a revisional surgery jumps to 12-13%, regardless of the size of the piece used. In general, females experience a higher rate of revision than male patients, probably because they are more likely to require the small head pieces for their body.
Because this data reveals such a high rate of patients requiring correctional surgery, DePuy issued the recall for all ASR products. Multiple health issues are caused by the defective piece, such as the product becoming loose, and/or the release of metal ions into the body, along with soft tissue damage.
If you are the recipient of a defective DePuy Hip Resurfacing System or ASR XL Acetabular System, we urge you to contact a DePuy hip replacement recall lawyer for a free, no obligation, consultation.